Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
09040-cover-NIHGenomicscxd.jpg

October 1, 2012 Cover

Volume 90, Issue 40

Finding new uses for approved drugs and shelved drug candidates is gaining steam as a pharmaceutical development strategy

Cover image:

Credit:

Full Article
Volume 90 | Issue 40

All Issues

Pharmaceuticals

Drug Repurposing

Finding new uses for approved drugs and shelved drug candidates is gaining steam as a pharmaceutical development strategy

  • ‘Looper’

    Sci-fi thriller provides a thought-provoking commentary on technology and time travel

  • Pfizer’s Academic Experiment

    The big pharma firm is banking on proximity to breed teamwork and ultimately improve the outcome of early-stage R&D

  • Talk, No Action On Nuclear Waste Plan

    Time slips by as U.S. continues impasse over fate of spent fuel, radioactive nuclear waste

ADVERTISEMENT
image name
Food Science

The Maillard Reaction Turns 100

Scientists celebrate the centennial of a reaction that makes cooked food tasty, but also produces worrisome molecules in our meals and bodies

ADVERTISEMENT
ADVERTISEMENT